The Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) have delayed the finalization of a rule meant to lock in addiction treatment-related telehealth flexibilities first implemented during the COVID-19 pandemic. On March 20, the agencies released the text of a final rule that pushed back the effective date of another final rule entitled “Expansion of Buprenorphine Treatment via Telemedicine Encounter” to the end of 2025.
Read the full article: DEA Unfreezes Telehealth Buprenorphine Prescribing Reg, Delays Implementation //
Source: https://bhbusiness.com/2025/03/25/dea-unfreezes-telehealth-buprenorphine-prescribing-reg-delays-implementation